MicroRNAs in idiopathic inflammatory myopathies: state-of-the-art and future perspectives.

IIMs comprise different clinical phenotypes and still little is known about the molecular signature of each subset. Further research about miRNA profiling will provide additional insights in the disease characterization with an expected impact on the therapeutic strategies.